Featured Research

from universities, journals, and other organizations

Treating sore throat should be part of strategy to prevent rheumatic heart disease

Date:
September 26, 2013
Source:
World Heart Federation
Summary:
Diagnosing and treating sore (strep) throat (primary prevention) in children and adolescents to prevent such cases developing into acute rheumatic fever and rheumatic heart disease (RHD) should be a cornerstone in any overall rheumatic heart disease strategy.

Diagnosing and treating sore (strep) throat (primary prevention) in children and adolescents to prevent such cases developing into acute rheumatic fever (ARF) and rheumatic heart disease (RHD) should be a cornerstone in any overall RHD strategy. The issues around primary prevention are discussed in one of the papers in the RHD special issue of Global Heart (the Journal of the World Heart Federation) by authors Dr Liesl Zühlke, University of Cape Town and Red Cross War Memorial Children's Hospital, Cape Town, South Africa, and Dr Ganesan Karthikeyan, All India Institute of Medical Sciences, New Delhi, India.

Up to one in four cases of sore throat are caused by Group A Streptococcal (GAS) infections that can lead if untreated to ARF/RHD. Simple treatment with oral penicillin or amoxicillin, or injected benzathine penicillin G (BPG-the same treatment used in secondary prevention) can cure such cases relatively easily and at low cost. Studies have found that treating strep throat with BGP can reduce the risk of subsequent ARF by 70-80%. "Primary prevention is an essential tool for prevention in the absence of a cure for ARF and RHD, and the monumental expense of surgical intervention in patients with these conditions," say the authors.

The obstacles to including primary prevention include the actual diagnosis of strep throat (group A strep pharyngitis), treatment options and patient and physician awareness about the possible consequences of an untreated sore throat. For many families in low-income and middle-income countries, a sore throat is simply not considered serious enough to warrant a visit to the nearest medical centre, which could be many miles away.

A further issue is the positioning of primary prevention within a control program, and whether introducing widespread screening and treatment in schools is cost-effective. Here, the authors point to the success that was had in Cuba, Costa Rica, Martinique, and Guadeloupe, all of who used a comprehensive strategy involving syndromic treatment of suspected GAS pharyngitis with penicillin which was introduced and maintained for over 10 years. There was also a concerted educational campaign that attempted to involve and target the public, social and educational professions, and media campaigns to raise awareness in each of these locations.

The authors say: "Following on from the excellent work carried out in Cuba, Costa Rica, and other countries, similar programs have now evolved in several other sites, a world-leadingprogram of RHD control in Pacific Island nations has individuals from Tonga, Fiji, and Samoa at the helm, whereas the ASAP (Advocacy, Surveillance, Awareness and Prevention) program, under the auspices of the Pan-African Society of Cardiology has galvanized efforts in Africa to combat this disease."

They add that these efforts have been met with renewed support from global organizations such as the World Heart Federation, which has made a major commitment to leading the charge on RHD control, supporting programs in the Pacific and Africa, establishing an international web-based resource in RF/RHD, and, in their most recent strategic plan, committing to 'eliminating rheumatic fever and minimizing the burden of rheumatic heart disease'.

They conclude: "Rheumatic heart disease is unique among chronic cardiovascular diseases in several ways. It is entirely preventable. It is among the few chronic cardiovascular diseases of childhood, adolescence, and young adulthood, and straddles the silos of infectious and non-communicable diseases and, therefore, represents perfectly the needs of developing countries in the 21st century, now dealing increasingly with this double burden. Primary prevention is the cornerstone of any RHD program and integration into existing primary care systems should be a priority."


Story Source:

The above story is based on materials provided by World Heart Federation. Note: Materials may be edited for content and length.


Cite This Page:

World Heart Federation. "Treating sore throat should be part of strategy to prevent rheumatic heart disease." ScienceDaily. ScienceDaily, 26 September 2013. <www.sciencedaily.com/releases/2013/09/130926204719.htm>.
World Heart Federation. (2013, September 26). Treating sore throat should be part of strategy to prevent rheumatic heart disease. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2013/09/130926204719.htm
World Heart Federation. "Treating sore throat should be part of strategy to prevent rheumatic heart disease." ScienceDaily. www.sciencedaily.com/releases/2013/09/130926204719.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) — The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) — An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) — Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) — Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins